MAPK1 and cancer: We also calculated the percentage of cancer types where the individualMAPK3 and MAPK1 genes and respectivegenecentric molecular pathways could be statistically significant potentialprognostic biomarkers according to the TCGA data(Table 4).Overall, the activation of molecular pathways was a putative prognosticbiomarker more frequently than the expression of the central genes of therespective pathways.